| |
|
|
|
Synthetic Biologics- Inc.  
|
|
0.2152 0.004 (0.02%) |
06-20 15:01 |
|
Open: |
0.2142 |
Pre close: |
0.2115 |
Target:
|
0.30
|
|
High: |
0.225 |
Low: |
0.21 |
Resistance:
|
0.25
0.28
|
|
Volume: |
694,819 |
Market Cap: |
28M |
Support:
|
0.21
0.17
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.22
 |
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
0.24 |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
0.32 |
Stochastic Oscillator |
%K(14,3):
|
8.93 |
|
MA(250): |
0.53 |
%D(3): |
20.76 |
|
Average Volume(K) |
3-Month: |
62647
|
52-Week |
High:
|
1.05 |
|
10-Days: |
60730 |
Low: |
0.19 |
|
RSI |
RSI(14):
|
37.94  |
Change(%): |
-69.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.170 |
Return on Equity (ttm) |
20337.4 |
Shares Out. (M) |
128.57 |
|
EPS Est. Current Year |
-0.170 |
Return on Assets (ttm) |
-131.4 |
Shares Float (M) |
123.05 |
|
EPS Est. Next Year |
-0.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.050 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
21.60 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
3830 |
|
Book Value (p.s.) |
21.960 |
EBITDA (p.s.) |
-0.095 |
P/E |
-1.26 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.01 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-20.27 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-20.03 |
P/CF |
-1.35 |
|
|
|
|
|
|
